Pharmacogenomics in Latin America: Challenges and Opportunities

Reseña

Table of Contents:
Foreword

Chapter 1. The Incorporation of Clinical Guidelines of Pharmacogenomics in Latin America => pp. 1-10
(Luis A. Quiñones and Ismael Lares-Asseff, Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Chile, and others)

Chapter 2. Genetic Variability and Response to Drugs in Latin American Populations: Ethnicity and Ancestry => pp. 11-24
(Idania Rodeiro Guerra and José Alfredo Herrera Isidrón, Pharmacology Department, Center of Marine Bioproducts, CEBIMAR, Environmental Agency, Havana, Cuba, and others)

Chapter 3. Pharmacogenomic Studies in Mexico, Central America and Cuba in Amerindians Groups: Clinical Applications and Toxicology => pp. 25-74
(Ismael Lares-Asseff, Fausto Zaruma Torres and Claudia E. Bailón-Soto, National Polytechnic Institute-CIIDIR, Durango, Mexico, and others)

Chapter 4. Clinical Pharmacogenomics in South America => pp. 75-92
(Juan Pablo Cayún, Carla Miranda, María Alejandra Lavanderos, Matías Martínez, Paula Escalante, Marcelo Suárez, Roberto Cerro, Christopher Sandoval, Leslie Cerpa, and Paulina Moreno, Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic-Clinic Oncology, Faculty of Medicine, University of Chile, Chile)

Chapter 5. Cost-Benefit Analysis in Pharmacogenomics: A Decompensated Ratio => pp. 93-108
(Fabrício Rios-Santos, Cinthia Vila Nova Santana, Luiz Alexandre Magno, and Antonio Macho, Departamento de Ciências Básicas em Saúde, Faculdade de Medicina, Universidade Federal de Mato Grosso, Brazil, and others)

Chapter 6. Pharmacogenomics, Regulatory Affairs and Public Health => pp. 109-124
(Diadelis Remirez Figueredo, National Centre for Quality Control of Drugs, Cuba)

Chapter 7. Pharmacogenomics in Psychiatric Practice: Latin America Initiatives => pp. 125-134
(Lina Ortiz L., Mauricio Moreno and Luis A. Quiñones, Department of Psychiatry, Clínica Las Condes, Santiago, Chile, and others)

Chapter 8. Cardiovascular Pharmacogenomics: Clinical Applications in Latin America => pp. 135-152
(Ángela M. Roco A., Luis A. Quiñones S. and Carla E. Miranda, Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Chile, and others)

Chapter 9. Cancer Pharmacogenomic Studies in Latin America => pp. 153-168
(Andrés López-Cortés, Santiago Guerrero and María Ana Redal, Biomedical Research Institute, Faculty of Health Sciences, Universidad de las Americas, Quito, Ecuador, and others)

Chapter 10. Pharmacogenomics of Antiretroviral Therapy in Latin America => pp. 169-194
(Nelson M. Varela and Fernando Bernal, Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Chile, and others)

Chapter 11. Molecular Bases of Epileptogenesis and Multidrug Resistance in Refractory Epilepsy: Latin American Approaches => pp. 195-206
(Lazarowski A. and Czornyj L., INFIBIOC-School of Pharmacy and Biochemistry- University of Buenos Aires, Argentina, and others)

Chapter 12. Pharmacoepigenomics of Cancer: Opportunities in Latin America => pp. 207-228
(Germán R. Perez, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Gammalab, Grupo Gamma SA, Argentina)

Chapter 13. Future Directions: Challenges, Opportunities and Limitations => pp. 229-238
(Maria A. Redal and Luis A. Quiñones, Institute of Physiopathology and Clinical Biochemistry, Faculty of Pharmacy and Biochemistry, University of Buenos Aires. CDM Center of Molecular Diagnostic, Argentina, and others)